LEAD Therapeutics
Drug discovery company developing small molecule ind candidates for the treatment of cancer and infectious diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€88m (Public information from Feb 2010)
San Bruno California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$17.0m | Series A | ||
N/A | $3.0m | Debt | |
$97.0m Valuation: $97.0m | Acquisition | ||
Total Funding | €15.5m |
Related Content
Recent News about LEAD Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.